Works in Leukemia & Lymphoma, 2020, Vol 61, Issue 7
Results: 41
The evolving definition of bulky disease for lymphoma.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1525, doi. 10.1080/10428194.2020.1797014
- By:
- Publication type:
- Article
Detection and clinical significance of gene rearrangements in Chinese patients with adult acute lymphoblastic leukemia.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1775, doi. 10.1080/10428194.2020.1794540
- Publication type:
- Article
Rituximab biosimilars in clinical practice.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1523, doi. 10.1080/10428194.2020.1788016
- By:
- Publication type:
- Article
Busulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation?
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1529, doi. 10.1080/10428194.2020.1767291
- By:
- Publication type:
- Article
The clinical outcomes of rituximab biosimilar CT-P10 (Truxima<sup>®</sup>) with CHOP as first-line treatment for patients with diffuse large B-cell lymphoma: real-world experience.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1575, doi. 10.1080/10428194.2020.1742906
- By:
- Publication type:
- Article
Cytogenetically masked CBFB-MYH11 fusion and concomitant TP53 deletion in a case of acute myeloid leukemia with a complex karyotype.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Mantle cell lymphoma turned SOX11 negative after ibrutinib: a report of two cases.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Pembrolizumab immunotherapy for relapsed CNS Lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1565, doi. 10.1080/10428194.2020.1742901
- By:
- Publication type:
- Article
Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 study.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1669, doi. 10.1080/10428194.2020.1742900
- By:
- Publication type:
- Article
Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1636, doi. 10.1080/10428194.2020.1737690
- By:
- Publication type:
- Article
Prognosis of MECOM (EVI1)-rearranged MDS and AML patients rather depends on accompanying molecular mutations than on blast count.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Daratumumab as successful initial therapy for AL amyloidosis with nerve involvement.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Prevalence and effects of polypharmacy on overall survival in acute myeloid leukemia.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1702, doi. 10.1080/10428194.2020.1737687
- By:
- Publication type:
- Article
Prognostic impact of low muscle mass and low muscle density in patients with diffuse large B-cell lymphoma.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1618, doi. 10.1080/10428194.2020.1737686
- By:
- Publication type:
- Article
Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1695, doi. 10.1080/10428194.2020.1737685
- By:
- Publication type:
- Article
Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1592, doi. 10.1080/10428194.2020.1737684
- By:
- Publication type:
- Article
Nationwide epidemiological survey of familial myelodysplastic syndromes/acute myeloid leukemia in Japan: a multicenter retrospective study.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1688, doi. 10.1080/10428194.2020.1734595
- By:
- Publication type:
- Article
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1653, doi. 10.1080/10428194.2020.1734594
- By:
- Publication type:
- Article
Evidence of BCR-ABL1-positive progenitor spread in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML).
- Published in:
- 2020
- By:
- Publication type:
- Letter
The economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapy.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1601, doi. 10.1080/10428194.2020.1734592
- By:
- Publication type:
- Article
Increased expression of miR-22 corresponds to the high-risk subtypes of myelodysplastic syndromes and lower OS rate.
- Published in:
- 2020
- By:
- Publication type:
- Letter
A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Relapse or refractory Hodgkin lymphoma: determining risk of relapse or progression after autologous stem-cell transplantation.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1548, doi. 10.1080/10428194.2020.1732959
- By:
- Publication type:
- Article
Hyperuricemia might promote thrombosis in essential thrombocythemia and polycythemia vera.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Mobilization kinetics of peripheral blood stem cells with rescue plerixafor – real-world experience from a single center.
- Published in:
- 2020
- By:
- Publication type:
- Letter
A comprehensive clinical study of integrins in acute lymphoblastic leukemia indicates a role of α6/CD49f in persistent minimal residual disease and α5 in the colonization of cerebrospinal fluid.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Late appearance of eosinophilia in myeloid blast phase of myeloid neoplasm with rearrangement of PDGFRβ.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasia.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1678, doi. 10.1080/10428194.2020.1731498
- By:
- Publication type:
- Article
A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1555, doi. 10.1080/10428194.2020.1731497
- By:
- Publication type:
- Article
Safety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm
- Published in:
- 2020
- By:
- Publication type:
- Letter
Thrombocytopenia in patients with myelofibrosis: management options in the era of JAK inhibitor therapy.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1535, doi. 10.1080/10428194.2020.1728752
- By:
- Publication type:
- Article
Longitudinal clonal architecture of acute myeloid leukemia with NPM1 driver insertion, early TET2 mutations and secondary e6a2 BCR-ABL1 rearrangement.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Prognostic value of the metabolic bulk volume in patients with diffuse large B-cell lymphoma on baseline <sup>18</sup>F-FDG PET-CT.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1584, doi. 10.1080/10428194.2020.1728750
- By:
- Publication type:
- Article
Ibrutinib related cerebral aspergillosis successfully treated with isavuconazole: a case report.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1627, doi. 10.1080/10428194.2020.1728748
- By:
- Publication type:
- Article
Monocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experience.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1645, doi. 10.1080/10428194.2020.1728747
- By:
- Publication type:
- Article
An AKR1C3-specific prodrug with potent anti-tumor activities against T-ALL.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1660, doi. 10.1080/10428194.2020.1728746
- By:
- Publication type:
- Article
Consolidation radiotherapy following positron emission tomography complete response in early-stage Hodgkin lymphoma: a meta-analysis.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1610, doi. 10.1080/10428194.2020.1725506
- By:
- Publication type:
- Article
Spontaneous remission and clonal evolution in lenalidomide associated secondary AML.
- Published in:
- 2020
- By:
- Publication type:
- Letter